Related references
Note: Only part of the references are listed.Long-term impact of androgen-deprivation therapy on physical function and quality of life
Shabbir M. H. Alibhai et al.
CANCER (2015)
Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled Comparison
Brian D. Gonzalez et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis
Heather L. McGinty et al.
SUPPORTIVE CARE IN CANCER (2014)
Long-Term Effects on Cognitive Function of Postmenopausal Hormone Therapy Prescribed to Women Aged 50 to 55 Years
Mark A. Espeland et al.
JAMA INTERNAL MEDICINE (2013)
Cancer- and Cancer Treatment-Associated Cognitive Change: An Update on the State of the Science
Tim A. Ahles et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
The Role of Androgens and Estrogens on Healthy Aging and Longevity
Astrid M. Horstman et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2012)
International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer
Jeffrey S. Wefel et al.
LANCET ONCOLOGY (2011)
Impact of Androgen-Deprivation Therapy on Physical Function and Quality of Life in Men With Nonmetastatic Prostate Cancer
Shabbir M. H. Alibhai et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Impact of Androgen-Deprivation Therapy on Cognitive Function in Men With Nonmetastatic Prostate Cancer
Shabbir M. H. Alibhai et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Long-term changes in bone mineral density and predicted fracture risk in patients receiving androgen-deprivation therapy for prostate cancer, with stratification of treatment based on presenting values
Vivek K. Wadhwa et al.
BJU INTERNATIONAL (2009)
Impact of Androgen Deprivation Therapy on Cardiovascular Disease and Diabetes
Shabbir M. H. Alibhai et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Cognitive Function Over Time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT)
ARCHIVES OF NEUROLOGY (2008)
Cognitive effects of hormone therapy in men with prostate cancer
Christian J. Nelson et al.
CANCER (2008)
Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop
J. Vardy et al.
ANNALS OF ONCOLOGY (2008)
Cytokine levels in patients (pts) with colorectal cancer and breast cancer and their relationship to fatigue and cognitive function
J. L. Vardy et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Evaluation of cognitive function associated with chemotherapy: A review of published studies and recommendations for future research
Janette Vardy et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma
VB Shahinian et al.
CANCER (2005)
Risk of fracture after androgen deprivation for prostate cancer
VB Shahinian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A systematic literature review of attrition between waves in longitudinal studies in the elderly shows a consistent pattern of dropout between differing studies
MD Chatfield et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2005)
Neuropsychological effects of treatments for adults with cancer: A meta-analysis and review of the literature
C Anderson-Hanley et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2003)
National practice patterns and time trends in androgen ablation for localized prostate cancer
MR Cooperberg et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Steroid hormones and cognitive functioning in aging men - A mini-review
BB Sherwin
JOURNAL OF MOLECULAR NEUROSCIENCE (2003)
Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial
HJ Green et al.
BJU INTERNATIONAL (2002)
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
M Bolla et al.
LANCET (2002)